Tom Baker Cancer Centre, Alberta Health Services

Calgary, Alberta T3N 4N1

1 studies enrolling now · 2 studies all time

What they study most

Metastatic Head-and-neck Squamous-cell Carcinoma, Multiple Myeloma, Recurrent Head and Neck Squamous Cell Carcinoma

Studies at this site

• A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma — Recruiting now
• Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile — Completed